Table 1.
N = 743 observations (using pooled 12/24 data in GEE models; N = 436 men) | Lifetime IPV victimization | IPV victimization in the last year | |||
---|---|---|---|---|---|
% (n/N) | Adjusteda PR [95% CI] Overall p value c |
% (n/N) | Adjusteda PR [95% CI] Overall p value c |
||
Study time-point | Month-12 | 44.9% (184/410) | 1 | 15.6% (64/410) | 1 |
Month-24 | 40.2% (134/333) | 0.92 [0.76, 1.10] | 14.7% (49/333) | 0.98 [0.69, 1.40] | |
0.36 | 0.93 | ||||
Randomized to study trial arm | Immediate | 42.0% (167/398) | 1 | 15.8% (63/398) | 1 |
Deferred | 43.8% (151/345) | 1.05 [0.82, 1.35] | 14.5% (50/345) | 0.89 [0.60, 1.32] | |
0.70 | 0.57 | ||||
London study clinic site | Yes | 40.6% (210/517) | 1 | 14.3% (74/517) | 1 |
No | 47.8% (108/226) | 1.18 [0.89, 1.56] | 17.3% (39/226) | 1.31 [0.85, 2.02] | |
0.24 | 0.23 | ||||
Age | < 25 | 55.3% (21/38) | 1.27 [0.75, 2.15] | 23.7% (9/38) | 1.61 [0.73, 3.59] |
25–29 | 48.4% (44/91) | 1.19 [0.80, 1.77] | 19.8% (18/91) | 1.32 [0.71, 2.44] | |
30–34 | 39.4% (63/160) | 0.94 [0.65, 1.36] | 13.1% (21/160) | 0.83 [0.45, 1.51] | |
35–39 | 47.2% (68/144) | 1.10 [0.76, 1.59] | 16.0% (23/144) | 1.02 [0.57, 1.84] | |
40–44 | 35.0% (44/125) | 0.86 [0.58, 1.28] | 11.2% (14/125) | 0.74 [0.38, 1.44] | |
45+ | 42.2% (78/185) | 1 | 15.1% (28/185) | 1 | |
0.61 | 0.44 | ||||
0.31 b | 0.27 b | ||||
Born in the UK and ethnicity (BAME = Black, Asian, and minority ethnic) | Yes, white | 45.0% (183/407) | 1 | 14.3% (58/407) | 1 |
Yes, BAME | 51.3% (20/39) | 1.18 [0.70, 1.99] | 20.5% (8/39) | 1.40 [0.63, 3.10] | |
No, white | 39.1% (79/202) | 0.90 [0.66, 1.23] | 12.9% (26/202) | 0.97 [0.58, 1.62] | |
No, BAME | 37.6% (35/93) | 0.84 [0.54, 1.31] | 22.6% (21/93) | 1.83 [1.04, 3.20] | |
0.69 | 0.15 | ||||
Self-reported sexual identity | Gay | 43.1% (303/703) | 1 | 15.2% (107/703) | 1 |
Bisexual/ straightd | 29.4% (10/34) | 0.62 [0.29, 1.30] | 14.7% (5/34) | 0.84 [0.32, 2.22] | |
0.21 | 0.73 | ||||
University Education | Yes | 42.0% (193/460) | 1 | 15.7% (72/460) | 1 |
No/missing | 44.2% (125/283) | 1.01 [0.77, 1.32] | 14.5% (41/283) | 0.84 [0.55, 1.29] | |
0.96 | 0.43 | ||||
Employed | Yes | 41.3% (251/608) | 1 | 14.5% (88/608) | 1 |
No/missing | 49.6% (67/135) | 1.17 [0.85, 1.62] | 18.5% (25/135) | 1.17 [0.70, 1.94] | |
0.33 | 0.55 | ||||
Had sex after using recreational drugs (past three months) | No/missing | 38.1% (137/360) | 1 | 10.8% (39/360) | 1 |
Yes | 47.3% (181/383) | 1.36 [1.08, 1.71] | 19.3% (74/383) | 1.92 [1.28, 2.90] | |
0.010 | 0.002 | ||||
Group sex (past three months) | No/missing | 42.1% (150/356) | 1 | 11.0% (39/356) | 1 |
Yes | 43.4% (168/387) | 1.10 [0.88, 1.38] | 19.1% (74/387) | 1.87 [1.25, 2.79] | |
0.38 | 0.002 | ||||
Age < 13 years at anal sex debut | No | 43.7% (295/675) | 1 | 15.3% (103/675) | 1 |
Yes | 53.7% (22/41) | 1.15 [0.72, 1.84] | 22.0% (9/41) | 1.49 [0.74, 3.03] | |
0.57 | 0.27 | ||||
Age ≤ 15 years at anal sex debut | No | 42.3% (236/558) | 1 | 14.7% (82/558) | 1 |
Yes | 51.3% (81/158) | 1.18 [0.89, 1.56] | 19.0% (30/158) | 1.33 [0.85, 2.08] | |
0.26 | 0.21 | ||||
Negative attitudes towards gay sexuality | No/missing | 38.3% (166/434) | 1 | 10.8% (47/434) | 1 |
Yes | 49.2% (152/309) | 1.31 [1.05, 1.64] | 21.4% (66/309) | 2.00 [1.36, 2.94] | |
0.016 | < 0.001 | ||||
‘Out’ to all/almost all friends, work mates, and close family | Yes | 44.6% (166/372) | 1 | 14.0% (52/372) | 1 |
No | 42.3% (150/355) | 1.08 [0.86, 1.36] | 17.2% (61/355) | 1.25 [0.85, 1.85] | |
0.52 | 0.25 | ||||
Lifetime IPV perpetration | No/missing | 32.0% (193/603) | 1 | 8.8% (53/603) | 1 |
Yes | 89.3% (125/140) | 2.69 [2.11, 3.42] | 42.9% (60/140) | 4.72 [3.22, 6.93] | |
< 0.001 | < 0.001 |
aAge (< 25, 25–29, 30–39, 40+), born in the UK, sexual identity (gay or bisexual/straight), university education, and London study clinic site
bTest for trend
cp value by Wald test using GEEs. p values< 0.1 are indicated in bold
dFive men identified as straight (1.2%)